NCT04445506View on ClinicalTrials.gov

Short Term Corticosteroids in SARS-CoV2 Patients

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

May 31, 2020

Study Completion Date

May 31, 2020

Conditions
CorticosteroidsCovid19SARS-CoV 2SteroidsDexamethasone
Interventions
DRUG

Dexamethasone

4mg dexamethasone was given to some patients three times daily for 2 days, 2 times daily for 2 days, once daily for 2 days.

Trial Locations (1)

02906

The Miriam Hospital, Providence

All Listed Sponsors
lead

The Miriam Hospital

OTHER

NCT04445506 - Short Term Corticosteroids in SARS-CoV2 Patients | Biotech Hunter | Biotech Hunter